Explore the complete record of transactions filed by Philippe Roussouly, Chairman & CEO. Insider active across 1 companies, notably S.M.A.I.O. Aggregated, 1 reports have been logged. Total volume traded: €44k. The latest transaction was disclosed on 16 March 2023 — Acquisition. Regulator: AMF. All data is accessible without signup.
1 of 1 declaration
Philippe Roussouly is the founder and Chief Executive Officer of SMAIO, a French medtech company focused on complex spine surgery and spinal realignment solutions. Founded in 2009, SMAIO was built around a model that combines clinical expertise, medical data, imaging, and implantable devices to improve outcomes in spinal deformity and complex orthopaedic procedures. As the company’s top executive, he oversees SMAIO’s strategy, product development, international expansion, and investor relations. Company investor materials show that in 2024 he led a major strategic shift by establishing SMAIO’s general and commercial management in the United States, a critical market for spinal implants, with the goal of accelerating growth and strengthening the group’s presence in North America. His career is closely tied to the orthopaedics and spine-surgery ecosystem. Sector and financial sources describe him as the company’s key leader, responsible for strategic direction, market development, and the relationship with institutional investors and industrial partners. He also played a central role in SMAIO’s listing on Euronext Growth Paris, a milestone that improved the company’s access to capital and visibility in the public markets. Under his leadership, SMAIO has strengthened both its scientific credibility and commercial reach. The company has highlighted the expansion of its training programs, deeper collaboration with reference medical centers, and the creation of a North American Scientific Advisory Board. It also emphasizes its capabilities in data, artificial intelligence, and spinal alignment planning, reflecting a clear focus on personalized surgery and precision medicine. Overall, Philippe Roussouly represents an entrepreneur-operating executive profile: he combines medical-sector expertise, company-building, stock-market discipline, and international execution. His leadership has helped transform SMAIO from a clinically driven innovator into a listed medtech company with a growing footprint in North America.